Stay updated on SAR442257 Clinical Trial in RRMM & RR-NHL
Sign up to get notified when there's something new on the SAR442257 Clinical Trial in RRMM & RR-NHL page.

Latest updates to the SAR442257 Clinical Trial in RRMM & RR-NHL page
- Check2 days agoChange DetectedThe ClinicalTrials.gov site revision displayed in the footer changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check9 days agoChange DetectedThe site revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check16 days agoChange DetectedA new study-record version dated 2026-09-29 was added, updating the study identification and status. The record now lists the trial as terminated, citing limited clinical benefit in both the multiple myeloma and non-Hodgkin lymphoma cohorts.SummaryDifference0.3%

- Check29 days agoChange DetectedA new revision entry v3.7.0 was added to the study record history, replacing the previous v3.6.6. This indicates an update to the page's version in the history log.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page now shows Revision: v3.6.6 as the latest record version, replacing Revision: v3.6.5.SummaryDifference0.1%

- Check64 days agoChange DetectedA new version entry on 2026-08-14 documents the termination of the study due to limited clinical benefit observed in both Multiple Myeloma and Non-Hodgkin Lymphoma cohorts, and updates the Study Status and Recruitment Status accordingly. The history also removes the prior 2026-05-29 entry that marked the study as Completed and References.SummaryDifference0.6%

Stay in the know with updates to SAR442257 Clinical Trial in RRMM & RR-NHL
Enter your email address, and we'll notify you when there's something new on the SAR442257 Clinical Trial in RRMM & RR-NHL page.